Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia

Completed · Phase 3 · Has a placebo group

Conditions studied: Parkinson's Disease, Dyskinesia

In brief

The purpose of this study is to test multiple doses of sarizotan to establish a dose with maximal safety and efficacy for treating treatment associated dyskinesia in Parkinson's disease participants.

Key facts

Study ID

NCT00105521

Run by

EMD Serono

People needed

398

Starts

2004-09-30

Expected to finish

2006-03-31

Last updated by the study team

2018-04-02

Who can join

Age: 30 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• The participant is an out-patient
• The participant presents with a diagnosis of idiopathic Parkinson's disease
• Prior therapy with all registered Parkinsonian medication is allowed

You may not qualify if…

• (For female participants) The participant is pregnant or lactating
• The participant is participating in another clinical study or has done so within the past 30 days
• The participant has received neurosurgical intervention related to Parkinson's disease
• The participant has relevant renal impairment
• The participant has relevant hepatic impairment
• The participant is suffering from any dementia or psychiatric illness
• The participant has a history of allergic asthma

Where it is running

• Study site — Phoenix, Arizona, United States
• Study site — Phoenix, Arizona, United States
• Study site — Phoenix, Arizona, United States
• Study site — Scottsdale, Arizona, United States
• Study site — Fayetteville, Arkansas, United States
• Study site — Fountain Valley, California, United States
• Study site — Los Angeles, California, United States
• Study site — Fort Lauderdale, Florida, United States
• Study site — Hollywood, Florida, United States
• Study site — Ocala, Florida, United States
• Study site — Port Charlotte, Florida, United States
• Study site — St. Petersburg, Florida, United States
• Study site — Tampa, Florida, United States
• Study site — Chicago, Illinois, United States
• Study site — Chicago, Illinois, United States
• Study site — Hoffman Estates, Illinois, United States
• Study site — Lexington, Kentucky, United States
• Study site — Baltimore, Maryland, United States
• Study site — Columbia, Maryland, United States
• Study site — Boston, Massachusetts, United States
• Study site — Boston, Massachusetts, United States
• Study site — Golden Valley, Minnesota, United States
• Study site — Omaha, Nebraska, United States
• Study site — Albany, New York, United States
• Study site — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.